Careplus Group Berhad

KLSE:CAREPLS Stock Report

Market Cap: RM 183.1m

Careplus Group Berhad Past Earnings Performance

Past criteria checks 0/6

Careplus Group Berhad's earnings have been declining at an average annual rate of -28.8%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been declining at an average rate of 16.2% per year.

Key information

-28.8%

Earnings growth rate

-28.3%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate-16.2%
Return on equity-9.3%
Net Margin-24.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Feb 07
Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Dec 18
Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Nov 23
Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Sep 07
Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Apr 01
Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly

Feb 28
Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly

Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?

Nov 30
Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?

Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?

Nov 12
Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?

Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?

May 16
Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Feb 26
Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Feb 13
Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Jan 17
Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Dec 13
Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Revenue & Expenses Breakdown

How Careplus Group Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KLSE:CAREPLS Revenue, expenses and earnings (MYR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2498-2450
30 Jun 2485-2630
30 Jun 23205-14750
31 Dec 22262-12290
30 Sep 22325-11990
30 Jun 22378-81100
31 Mar 2254160140
31 Dec 21700221180
30 Sep 21721279190
30 Jun 21742314180
31 Mar 21612245170
31 Dec 20476122130
30 Sep 2045581110
30 Jun 2041733110
31 Mar 20385-590
31 Dec 19365-690
30 Sep 19346-8110
30 Jun 19351-2110
31 Mar 19345-1110
31 Dec 18339-1110
30 Sep 18325-1100
30 Jun 18314-3100
31 Mar 18314-6110
31 Dec 17323-2110
30 Sep 173161110
30 Jun 172950110
31 Mar 172673110
31 Dec 162290100
30 Sep 162100100
30 Jun 162033100
31 Mar 161954100
31 Dec 151906100
30 Sep 15182590
30 Jun 15169580
31 Mar 15159480
31 Dec 14152370

Quality Earnings: CAREPLS is currently unprofitable.

Growing Profit Margin: CAREPLS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CAREPLS is unprofitable, and losses have increased over the past 5 years at a rate of 28.8% per year.

Accelerating Growth: Unable to compare CAREPLS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CAREPLS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.4%).


Return on Equity

High ROE: CAREPLS has a negative Return on Equity (-9.27%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/24 10:31
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Careplus Group Berhad is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason YapOSK-DMG
Voon ChongRHB Investment Bank